0002-7772 : Ebglyss 250 mg/2ml Subcutaneous Injection, Solution
NDC: | 0002-7772 |
Labeler: | Eli Lilly and Company |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761306 |
Rev. Date: |
NDC Package Codes:
- 0002-7772-11: 1 SYRINGE IN 1 CARTON (0002‑7772‑11) / 1 ML IN 1 SYRINGE (0002‑7772‑01)
- 0002-7772-62: 2 SYRINGE IN 1 CARTON (0002‑7772‑62) / 1 ML IN 1 SYRINGE
Active Ingredients:
- Lebrikizumab
Dosage Strength:
- 250 mg/2mL
Pharmaceutical Classes:
- Interleukin-13 Antagonist [EPC]
- Interleukin-13 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 0002-7797 Ebglyss 250 mg/2ml Subcutaneous Injection, Solution by Eli Lilly and Company
NDC QR Code
Scan the QR code below to easily reference this data in the future:![NDC 0002-7772 QR Code](/images/NDC-QR/0002-7772-QR.png)
< Prev: 0002-7752Next: 0002-7797 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.